Systemic inflammatory index correlates with cerebral small vessel disease in Parkinson's disease.

Authors

Yongqing Cheng, Haiping Tang, Shuangfei You, Xin Wang, Lei Li, Songjie Chen, Shouru Xue, Guojun He

Published in

Frontiers in aging neuroscience. Volume 18. Pages 1748084. Epub Jun 03, 2026.

Abstract

This study investigates the association between systemic inflammatory indices-specifically, the systemic immune inflammation index (SII) and systemic inflammation response index (SIRI)-and the severity of cerebral small vessel disease (CSVD) in patients with Parkinson's disease (PD).
A total of 167 patients with primary PD and complete MRI data were included. CSVD severity was assessed using total and modified CSVD burden scores, with patients categorized into two groups: mild (scores 0-1 or 0-2) and moderate-severe (scores 2-4 or 3-6). Logistic and ROC analyses were employed to evaluate the association and discriminative ability of SII and SIRI for CSVD severity.
Among 167 patients (59.3% male, mean age 69.6 ± 8.7 years), 91 and 96 were classified with moderate-severe CSVD based on total and modified scores, respectively. Higher SII and SIRI levels, along with a greater proportion of hypertension, were observed in the moderate-severe CSVD group. Spearman analysis indicated SII weakly correlated with both CSVD scores (total: r = 0.224, p = 0.004; modified: r = 0.155, p = 0.046), while SIRI showed a weak correlation with the total score only (r = 0.179, p = 0.021). After adjusting for covariates, logistic regression showed the highest tertiles of SII and SIRI were significantly associated with moderate-severe CSVD, whether using the total score (T3 vs. T1: OR 2.919, 95% CI 1.191-7.153 for SII; OR 4.295, 95% CI 1.681-10.973 for SIRI) or the modified score (T3 vs. T1: OR 4.196, 95% CI 1.705-10.327 for SII; OR 3.303, 95% CI 1.326-8.226 for SIRI).
Although their individual discriminatory abilities are limited, elevated SII and SIRI are independently associated with more severe CSVD in PD patients.

PMID:
42318559
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.